Petros Pharmaceuticals, Inc. cotiza a 0.00 USD y tiene una capitalización bursátil de $127117. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
| Periodo | 2024-11 | 2024-08 | 2024-05 | 2024-04 |
|---|---|---|---|---|
| Real | $-13.25 | $-9.25 | $-42.25 | $-54.25 |
| Estimado | $-7.25 | $-19.25 | $-36.00 | $-27.75 |
| Sorpresa | -82.8% | +51.9% | -17.4% | -95.5% |
| Métrica | PTPI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | 66.7% | -40.4% | +107.1% |
| ROA | 37.1% | -32.0% | +69.1% |
| Current Ratio | 2.25 | 2.84 | -0.59 |
| Debt / Equity | — | 0.28 | — |